End-of-day quote
New Zealand S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
34.3
NZD
|
-3.24%
|
|
-1.12%
|
-3.38%
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,715
|
3,493
|
5,284
|
7,388
|
7,041
|
6,628
|
-
|
-
|
Enterprise Value (EV)
1 |
4,103
|
3,851
|
5,607
|
8,346
|
7,870
|
7,795
|
7,645
|
7,571
|
P/E ratio
|
24.3
x
|
19.6
x
|
27.2
x
|
30.6
x
|
25.6
x
|
21.4
x
|
22.4
x
|
19.3
x
|
Yield
|
3.09%
|
3.71%
|
2.68%
|
2.75%
|
2.96%
|
3.42%
|
3.31%
|
3.71%
|
Capitalization / Revenue
|
0.51
x
|
0.36
x
|
0.55
x
|
0.62
x
|
0.53
x
|
0.48
x
|
0.54
x
|
0.51
x
|
EV / Revenue
|
0.56
x
|
0.4
x
|
0.58
x
|
0.7
x
|
0.6
x
|
0.56
x
|
0.62
x
|
0.58
x
|
EV / EBITDA
|
15.5
x
|
11.9
x
|
14.6
x
|
17.2
x
|
12.5
x
|
11.7
x
|
12
x
|
11
x
|
EV / FCF
|
42.1
x
|
17.6
x
|
-
|
47
x
|
24.9
x
|
33.9
x
|
17.9
x
|
20
x
|
FCF Yield
|
2.38%
|
5.69%
|
-
|
2.13%
|
4.02%
|
2.95%
|
5.57%
|
5%
|
Price to Book
|
2.82
x
|
2.44
x
|
3.58
x
|
2.92
x
|
2.66
x
|
2.54
x
|
2.49
x
|
2.41
x
|
Nbr of stocks (in thousands)
|
160,483
|
161,639
|
163,579
|
189,383
|
191,604
|
193,232
|
-
|
-
|
Reference price
2 |
23.15
|
21.61
|
32.30
|
39.01
|
36.75
|
34.30
|
34.30
|
34.30
|
Announcement Date
|
8/21/19
|
8/19/20
|
8/17/21
|
8/23/22
|
8/22/23
|
-
|
-
|
-
|
Fiscal Period: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
7,342
|
9,593
|
9,652
|
11,952
|
13,223
|
13,943
|
12,384
|
13,007
|
EBITDA
1 |
264.9
|
324.6
|
385
|
486.3
|
628.9
|
663.8
|
636.8
|
689.1
|
EBIT
1 |
231.1
|
285.4
|
308.9
|
395.3
|
523.2
|
552.4
|
519.1
|
570.5
|
Operating Margin
|
3.15%
|
2.98%
|
3.2%
|
3.31%
|
3.96%
|
3.96%
|
4.19%
|
4.39%
|
Earnings before Tax (EBT)
1 |
204.5
|
251.8
|
275.8
|
328.8
|
403.5
|
442.3
|
423.2
|
474.6
|
Net income
1 |
145.9
|
177.8
|
194.3
|
225.6
|
273.8
|
311.8
|
294.9
|
338.6
|
Net margin
|
1.99%
|
1.85%
|
2.01%
|
1.89%
|
2.07%
|
2.24%
|
2.38%
|
2.6%
|
EPS
2 |
0.9513
|
1.101
|
1.187
|
1.275
|
1.436
|
1.603
|
1.531
|
1.777
|
Free Cash Flow
1 |
97.46
|
219.2
|
-
|
177.5
|
316.6
|
230
|
426
|
378.5
|
FCF margin
|
1.33%
|
2.29%
|
-
|
1.49%
|
2.39%
|
1.65%
|
3.44%
|
2.91%
|
FCF Conversion (EBITDA)
|
36.79%
|
67.53%
|
-
|
36.5%
|
50.35%
|
34.65%
|
66.89%
|
54.93%
|
FCF Conversion (Net income)
|
66.81%
|
123.26%
|
-
|
78.69%
|
115.65%
|
73.76%
|
144.48%
|
111.79%
|
Dividend per Share
2 |
0.7150
|
0.8022
|
0.8649
|
1.071
|
1.087
|
1.172
|
1.136
|
1.272
|
Announcement Date
|
8/21/19
|
8/19/20
|
8/17/21
|
8/23/22
|
8/22/23
|
-
|
-
|
-
|
Fiscal Period: Juni |
2020 S1
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
4,574
|
5,022
|
4,771
|
5,658
|
6,105
|
6,790
|
6,582
|
6,993
|
6,895
|
EBITDA
1 |
174.8
|
-
|
191.9
|
223.8
|
255.1
|
319.5
|
316.4
|
332.7
|
343.9
|
EBIT
1 |
137.4
|
-
|
153.9
|
182.2
|
207
|
249.7
|
278.9
|
276.1
|
288.2
|
Operating Margin
|
3%
|
-
|
3.22%
|
3.22%
|
3.39%
|
3.68%
|
4.24%
|
3.95%
|
4.18%
|
Earnings before Tax (EBT)
|
-
|
-
|
137.6
|
-
|
164.9
|
212.8
|
195.4
|
-
|
-
|
Net income
1 |
-
|
-
|
96.91
|
109.8
|
-
|
146
|
-
|
144.7
|
160.4
|
Net margin
|
-
|
-
|
2.03%
|
1.94%
|
-
|
2.15%
|
-
|
2.07%
|
2.33%
|
EPS
|
-
|
-
|
0.5916
|
-
|
-
|
-
|
0.6840
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
0.4774
|
-
|
-
|
-
|
0.5620
|
0.6058
|
Announcement Date
|
2/19/20
|
2/17/21
|
8/17/21
|
2/15/22
|
8/23/22
|
2/21/23
|
8/22/23
|
2/20/24
|
-
|
Fiscal Period: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
388
|
358
|
323
|
958
|
828
|
1,167
|
1,018
|
943
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.463
x
|
1.103
x
|
0.84
x
|
1.97
x
|
1.317
x
|
1.759
x
|
1.598
x
|
1.369
x
|
Free Cash Flow
1 |
97.5
|
219
|
-
|
178
|
317
|
230
|
426
|
378
|
ROE (net income / shareholders' equity)
|
12%
|
12.7%
|
13.8%
|
12.4%
|
12%
|
12.4%
|
11.5%
|
12.6%
|
ROA (Net income/ Total Assets)
|
4.47%
|
4.68%
|
4.89%
|
4.47%
|
4.4%
|
5.96%
|
5.73%
|
6.21%
|
Assets
1 |
3,263
|
3,803
|
3,973
|
5,049
|
6,217
|
5,234
|
5,142
|
5,448
|
Book Value Per Share
2 |
8.200
|
8.870
|
9.030
|
13.30
|
13.80
|
13.50
|
13.80
|
14.20
|
Cash Flow per Share
2 |
0.8200
|
1.550
|
1.910
|
1.570
|
2.220
|
2.300
|
2.190
|
2.250
|
Capex
1 |
28.2
|
31.6
|
81.1
|
100
|
106
|
112
|
63.6
|
60.2
|
Capex / Sales
|
0.38%
|
0.33%
|
0.84%
|
0.84%
|
0.8%
|
0.8%
|
0.51%
|
0.46%
|
Announcement Date
|
8/21/19
|
8/19/20
|
8/17/21
|
8/23/22
|
8/22/23
|
-
|
-
|
-
|
Last Close Price
34.3
NZD Average target price
37.94
NZD Spread / Average Target +10.62% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.38% | 3.93B | | +17.35% | 71.39B | | +5.38% | 8.59B | | +6.69% | 8.19B | | -20.96% | 7.91B | | +0.49% | 4.54B | | +17.12% | 4.31B | | -2.61% | 3.86B | | +22.08% | 3.64B | | +7.96% | 3.29B |
Pharmaceuticals Wholesale
|